German Merck looks to capitalize on growth in Chinese healthcare spending

Merck KGaA (MKGAF) plans to spend $107.67M on a Chinese manufacturing facility.

When it comes online in 2017, the plant will produce treatments for diabetes, and cardiovascular disorders for China, where healthcare spending is projected to hit $1T by 2020.

Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs